{ "as_of": "2026-11-06", "cmr": "ca-cm-kg/TSX/MSCL", "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.", "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# Satellos Bioscience Inc. (TSX: MSCL) — research page\n\nAs of 2026-11-06 · ca-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is Satellos Bioscience Inc., listed on the TSX under ticker MSCL, with ISIN CA80401L8033. The LEI is not on the record, as the ISIN is not in the GLEIF ISIN-to-LEI mapping file. The security type is Corporate, the sector is Life Sciences, and the jurisdiction is Canada (federal, CBCA). The segment is not on the record. The listing status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 7 filings in the twelve months to 2026-11-06, on 7 filing days. By type, 1 is an AGM record date and 6 are newswire releases. The median gap between filing days is 15.0 days. The latest filing is dated 2026-11-06, is a newswire release, and is 0 days before the record date. The TSX exchange median is 16 days cadence, 0.0 filings and 3.0 days latency across 2270 issuers. The Life Sciences sector median is 17.5 days cadence, 7.0 filings and 14 days latency across 200 issuers. The issuer's median cadence of 15.0 days is below the exchange median of 16 days and below the sector median of 17.5 days. The issuer's 7 filings are above the exchange median of 0.0 filings and equal to the sector median of 7.0 filings. The issuer's latency of 0 days is below the exchange median of 3.0 days and below the sector median of 14 days.\n\n## Auditor\n\nThe auditor of record is PricewaterhouseCoopers LLP. Its location is not on the record. The record holds no auditor changes.\n\n## Events and halts\n\nThe record holds no listing, delisting, domicile change, name change or segment move lines. The halt flag is listed, not halted.\n\n## Orderability\n\nUnder the rule version acm-68000/ca/kyp-know-your-product-ni-31-103/r1, with the chapter as of 2026-11-04, the outcome for Paragraph (o) of the definition is signal ACM-200, determinable. The outcome for Paragraph (q) of the definition is signal ACM-200, determinable.\n\n## Coverage\n\nThe field has not been read. The number of research houses named on the issuer's investor-relations page is not on the record.\n\n## Open research\n\nThe field has not been read. The count of openly published research notes is not on the record.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe market's vintage is not sealed. No issuer years are sealed on the record. The live record began on 2026-09-10. The years 2021, 2022, 2023, 2024, 2025 and 2026 are sealed in the store but not served as of a date. The as-of door answers not_sealed.\n\n## Sources\n\n9 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://www.tsx.com/json/company-directory/search/tsx/^* (identity.exchange)\n- https://www.marketscreener.com/quote/stock/SATELLOS-BIOSCIENCE-INC-6499669/quotes (identity.isin)\n- https://s203.q4cdn.com/439234936/files/doc_financials/2022/q4/2022-Year-End-Financials-1.pdf (identity.jurisdiction)\n- https://www.tsx.com/en/resource/571 (identity.sector)\n- https://mcp.ca-cm-kg.ai/events/TSX/MSCL (the disclosure lines)\n- https://iiroc.mediaroom.com/index.php?s=2429&l=100 (the halt flag)\n- https://www.stocktitan.net/sec-filings/MSLE/6-k-satellos-bioscience-inc-current-report-foreign-issuer-aca0f7960101.html (the auditor)\n- https://mcp.ca-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://mcp.ca-cm-kg.ai/record/TSX/MSCL (the record)\n", "market": "CA", "node": "ca-cm-kg", "numbers": { "as_of_depth": { "issuer_years_sealed": [], "live_record_began": "2026-09-10", "node_history_from": null, "node_years_sealed": [], "note": "6 years are sealed in the CA store; their Replay split is not built, so the as-of door answers not_sealed and the record is the live record as of 2026-11-06", "record_version": 1, "sealed": false, "store_years_sealed_not_served": [ "2021", "2022", "2023", "2024", "2025", "2026" ] }, "auditor": { "auditor": { "read_by": "Tavily regex", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://www.stocktitan.net/sec-filings/MSLE/6-k-satellos-bioscience-inc-current-report-foreign-issuer-aca0f7960101.html", "state": "sourced", "value": "PricewaterhouseCoopers LLP" }, "auditor_firm_id": { "market": "CA", "state": "not_on_record" }, "auditor_location": { "market": "CA", "state": "not_on_record" }, "changes": [] }, "cmr": "ca-cm-kg/TSX/MSCL", "coverage": { "note": "the coverage field has not been read for this issuer", "state": "not_read" }, "disclosure": { "against": { "exchange": { "issuers": 2270, "median_cadence_gap_days": 16, "median_filings": 0, "median_latency_days": 3, "name": "TSX" }, "sector": { "issuers": 200, "median_cadence_gap_days": 17.5, "median_filings": 7, "median_latency_days": 14, "name": "Life Sciences" } }, "by_type": { "agm_record_date": 1, "newswire_release": 6 }, "cadence_median_gap_days": 15, "filing_days": 7, "filings": 7, "latency_days": 0, "latest": [ { "category": null, "date": "2026-11-06", "source": "https://www.globenewswire.com/news-release/2026/11/06/3397433/0/en/satellos-changes-primary-efficacy-endpoint-in-basecamp-phase-2-pediatric-trial-to-mri-measured-fat-fraction-following-fda-feedback.html", "title": "Satellos Changes Primary Efficacy Endpoint in BASECAMP", "type": "newswire_release" }, { "category": null, "date": "2026-11-05", "source": "https://www.globenewswire.com/news-release/2026/11/05/3397168/0/en/satellos-to-host-investor-call-to-provide-an-update-on-clinical-and-regulatory-strategy-for-the-basecamp-phase-2-pediatric-study.html", "title": "Satellos to Host Investor Call to Provide an Update on", "type": "newswire_release" }, { "category": null, "date": "2026-10-27", "source": "https://www.globenewswire.com/news-release/2026/10/27/3388825/0/en/satellos-establishes-scientific-advisory-board-to-explore-the-biology-of-regeneration-in-aging-and-neuroscience.html", "title": "Satellos Establishes Scientific Advisory Board to Explore", "type": "newswire_release" }, { "category": null, "date": "2026-10-21", "source": "https://www.globenewswire.com/news-release/2026/10/21/3385357/0/en/satellos-to-participate-in-upcoming-investor-conferences.html", "title": "Satellos to Participate in Upcoming Investor Conferences", "type": "newswire_release" }, { "category": null, "date": "2026-09-30", "source": "https://www.globenewswire.com/news-release/2026/09/30/3371742/0/en/satellos-announces-completion-of-enrollment-in-basecamp-phase-2-clinical-trial-of-forazapadin-for-duchenne-muscular-dystrophy.html", "title": "Satellos Announces Completion of Enrollment in BASECAMP", "type": "newswire_release" } ], "latest_filing_date": "2026-11-06", "read": "the node's event lines (list_events_since), as get_filings serves them", "source": "https://mcp.ca-cm-kg.ai/events/TSX/MSCL", "window": { "from": "2025-11-06", "to": "2026-11-06" } }, "identity": { "exchange": { "read_by": "tsx.com company directory (exchange list)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://www.tsx.com/json/company-directory/search/tsx/^*", "state": "sourced", "value": "TSX" }, "isin": { "read_by": "Tavily search + regex extraction from page text", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://www.marketscreener.com/quote/stock/SATELLOS-BIOSCIENCE-INC-6499669/quotes", "state": "confirmed", "value": "CA80401L8033" }, "jurisdiction": { "read_by": "Tavily search + regex extraction from page text", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://s203.q4cdn.com/439234936/files/doc_financials/2022/q4/2022-Year-End-Financials-1.pdf", "state": "sourced", "value": "Canada (federal, CBCA)" }, "lei": { "market": "CA", "reason": "ISIN not in the GLEIF ISIN-to-LEI mapping file", "state": "not_on_record" }, "name": { "read_by": "tsx.com company directory (exchange list)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://www.tsx.com/json/company-directory/search/tsx/^*", "state": "sourced", "value": "Satellos Bioscience Inc." }, "sector": { "read_by": "TMX listed-companies workbook (exchange list, monthly; data month named in the source column)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://www.tsx.com/en/resource/571 (tsx-and-amp-tsxv-listed-companies-2026-08-14-en.xlsx, data as of 31-Jul-2026)", "state": "sourced", "value": "Life Sciences" }, "security_type": { "read_by": "TMX listed-companies workbook (exchange list, monthly; data month named in the source column)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://www.tsx.com/en/resource/571 (tsx-and-amp-tsxv-listed-companies-2026-08-14-en.xlsx, data as of 31-Jul-2026)", "state": "sourced", "value": "Corporate" }, "segment": { "market": "CA", "state": "not_on_record" }, "ticker": { "read_by": "tsx.com company directory (exchange list)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://www.tsx.com/json/company-directory/search/tsx/^*", "state": "sourced", "value": "MSCL" }, "website": { "market": "CA", "state": "not_on_record" } }, "licensed": { "columns": [ "licensor", "entitlement", "title", "date", "source" ], "rows": [], "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded." }, "lifecycle": { "delisting": [], "domicile_change": [], "listing": [], "name_change": [], "segment_move": [] }, "market": "CA", "node": "ca-cm-kg", "numbers_hash": "sha256:f52d24f0c4c77c36160e5bbe68c3fe724761f57cdfe924ede3bbd42170deb845", "open_research": { "rows": [], "state": "not_read" }, "orderability": { "chapter_as_of": "2026-11-04", "client_categories": [ "Paragraph (o) of the definition", "Paragraph (q) of the definition" ], "outcomes": { "Paragraph (o) of the definition": { "determinable": true, "signal": "ACM-200" }, "Paragraph (q) of the definition": { "determinable": true, "signal": "ACM-200" } }, "read": { "basis": "one live read per instrument class, halt state and client category on this market; this issuer's group", "chapter": "https://mcp.ca-cm-kg.ai/book/aio.json", "door": "https://mcp.ca-cm-kg.ai/mcp", "tool": "get_orderability" }, "rule_version": "acm-68000/ca/kyp-know-your-product-ni-31-103/r1", "section": "ca.aio.v11" }, "record": { "as_of": "2026-11-06", "url": "https://mcp.ca-cm-kg.ai/record/TSX/MSCL", "version": 1 }, "schema": "research-numbers v0.1 (USR-01, 2026-11-11)", "status": { "read_date": "2026-11-08", "source": "https://iiroc.mediaroom.com/index.php?s=2429&l=100", "value": "listed, not halted" } }, "numbers_hash": "sha256:f52d24f0c4c77c36160e5bbe68c3fe724761f57cdfe924ede3bbd42170deb845", "path": "/ca/TSX/MSCL", "schema": "research-page v0.1 (USR-02, 2026-11-11)", "sections": [ { "id": "identity", "text": "The issuer is Satellos Bioscience Inc., listed on the TSX under ticker MSCL, with ISIN CA80401L8033. The LEI is not on the record, as the ISIN is not in the GLEIF ISIN-to-LEI mapping file. The security type is Corporate, the sector is Life Sciences, and the jurisdiction is Canada (federal, CBCA). The segment is not on the record. The listing status is listed, not halted.", "title": "Identity and listing" }, { "id": "disclosure", "text": "The record holds 7 filings in the twelve months to 2026-11-06, on 7 filing days. By type, 1 is an AGM record date and 6 are newswire releases. The median gap between filing days is 15.0 days. The latest filing is dated 2026-11-06, is a newswire release, and is 0 days before the record date. The TSX exchange median is 16 days cadence, 0.0 filings and 3.0 days latency across 2270 issuers. The Life Sciences sector median is 17.5 days cadence, 7.0 filings and 14 days latency across 200 issuers. The issuer's median cadence of 15.0 days is below the exchange median of 16 days and below the sector median of 17.5 days. The issuer's 7 filings are above the exchange median of 0.0 filings and equal to the sector median of 7.0 filings. The issuer's latency of 0 days is below the exchange median of 3.0 days and below the sector median of 14 days.", "title": "The disclosure read" }, { "id": "auditor", "text": "The auditor of record is PricewaterhouseCoopers LLP. Its location is not on the record. The record holds no auditor changes.", "title": "Auditor" }, { "id": "events", "text": "The record holds no listing, delisting, domicile change, name change or segment move lines. The halt flag is listed, not halted.", "title": "Events and halts" }, { "id": "orderability", "text": "Under the rule version acm-68000/ca/kyp-know-your-product-ni-31-103/r1, with the chapter as of 2026-11-04, the outcome for Paragraph (o) of the definition is signal ACM-200, determinable. The outcome for Paragraph (q) of the definition is signal ACM-200, determinable.", "title": "Orderability" }, { "id": "coverage", "text": "The field has not been read. The number of research houses named on the issuer's investor-relations page is not on the record.", "title": "Coverage" }, { "id": "open_research", "text": "The field has not been read. The count of openly published research notes is not on the record.", "title": "Open research" }, { "id": "licensed", "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.", "title": "Licensed" }, { "id": "depth", "text": "The market's vintage is not sealed. No issuer years are sealed on the record. The live record began on 2026-09-10. The years 2021, 2022, 2023, 2024, 2025 and 2026 are sealed in the store but not served as of a date. The as-of door answers not_sealed.", "title": "As-of depth" }, { "id": "sources", "text": "9 source pages are named on this page; every value above carries its own source page and read date in the numbers.", "title": "Sources" } ], "sources": [ { "for": "identity.exchange", "source": "https://www.tsx.com/json/company-directory/search/tsx/^*" }, { "for": "identity.isin", "source": "https://www.marketscreener.com/quote/stock/SATELLOS-BIOSCIENCE-INC-6499669/quotes" }, { "for": "identity.jurisdiction", "source": "https://s203.q4cdn.com/439234936/files/doc_financials/2022/q4/2022-Year-End-Financials-1.pdf" }, { "for": "identity.sector", "source": "https://www.tsx.com/en/resource/571" }, { "for": "the disclosure lines", "source": "https://mcp.ca-cm-kg.ai/events/TSX/MSCL" }, { "for": "the halt flag", "source": "https://iiroc.mediaroom.com/index.php?s=2429&l=100" }, { "for": "the auditor", "source": "https://www.stocktitan.net/sec-filings/MSLE/6-k-satellos-bioscience-inc-current-report-foreign-issuer-aca0f7960101.html" }, { "for": "the orderability chapter", "source": "https://mcp.ca-cm-kg.ai/book/aio.json" }, { "for": "the record", "source": "https://mcp.ca-cm-kg.ai/record/TSX/MSCL" } ], "title": "Satellos Bioscience Inc. (MSCL) — research page", "writer": { "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers", "engine": "claude-haiku-5-5" } }